In March 2025, the company announced new strategies for a direct-to-consumer giving of its Wegovy weight loss drug. The company proven a new pharmacy, known as NovoCare, which might demand customers $499 each month for access to the drug, below fifty percent the cost of the drug by way of other pharmaceutical distribution networks.[53]Allergic resp